Johnson Financial Group Inc. Buys 203 Shares of AMETEK, Inc. (NYSE:AME)

Johnson Financial Group Inc. raised its stake in AMETEK, Inc. (NYSE:AMEFree Report) by 90.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 428 shares of the technology company’s stock after buying an additional 203 shares during the period. Johnson Financial Group Inc.’s holdings in AMETEK were worth $79,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Versant Capital Management Inc boosted its stake in shares of AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company’s stock valued at $35,000 after purchasing an additional 187 shares in the last quarter. AdvisorNet Financial Inc boosted its stake in shares of AMETEK by 1,176.5% in the 4th quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company’s stock valued at $39,000 after purchasing an additional 200 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of AMETEK by 42.9% in the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after purchasing an additional 70 shares in the last quarter. OFI Invest Asset Management purchased a new stake in shares of AMETEK in the 4th quarter valued at $43,000. Finally, Anchor Investment Management LLC boosted its stake in shares of AMETEK by 366.1% in the 3rd quarter. Anchor Investment Management LLC now owns 261 shares of the technology company’s stock valued at $45,000 after purchasing an additional 205 shares in the last quarter. Institutional investors own 87.43% of the company’s stock.

AMETEK Stock Down 0.3 %

Shares of NYSE AME opened at $166.24 on Tuesday. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33. The firm has a market capitalization of $38.36 billion, a PE ratio of 28.03, a price-to-earnings-growth ratio of 2.73 and a beta of 1.14. The firm has a fifty day simple moving average of $171.63 and a two-hundred day simple moving average of $179.53.

AMETEK (NYSE:AMEGet Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.02. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.82 billion. AMETEK had a net margin of 19.83% and a return on equity of 16.94%. AMETEK’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same period last year, the business earned $1.68 EPS. Equities analysts expect that AMETEK, Inc. will post 7.15 earnings per share for the current year.

AMETEK declared that its Board of Directors has authorized a share buyback plan on Friday, February 7th that authorizes the company to buyback $1.25 billion in outstanding shares. This buyback authorization authorizes the technology company to buy up to 2.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

AMETEK Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Friday, March 14th were paid a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 0.75%. This is a positive change from AMETEK’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, March 14th. AMETEK’s dividend payout ratio (DPR) is presently 20.91%.

Insider Buying and Selling

In other AMETEK news, Director Steven W. Kohlhagen sold 1,320 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $189.41, for a total transaction of $250,021.20. Following the completion of the sale, the director now directly owns 22,029 shares in the company, valued at approximately $4,172,512.89. This trade represents a 5.65 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas A. Amato sold 710 shares of the firm’s stock in a transaction dated Thursday, March 27th. The shares were sold at an average price of $176.64, for a total transaction of $125,414.40. Following the sale, the director now owns 10,560 shares of the company’s stock, valued at approximately $1,865,318.40. This represents a 6.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.57% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AME. Truist Financial cut their price objective on shares of AMETEK from $216.00 to $196.00 and set a “buy” rating for the company in a research note on Tuesday, April 8th. Robert W. Baird dropped their price target on shares of AMETEK from $200.00 to $197.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Morgan Stanley began coverage on shares of AMETEK in a research report on Monday, April 14th. They set an “equal weight” rating and a $170.00 price target for the company. BNP Paribas raised shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 price target for the company in a research report on Thursday, January 16th. Finally, StockNews.com cut shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $198.60.

Get Our Latest Stock Report on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Featured Stories

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.